Literature DB >> 23960074

Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins.

Huafei Zou1, Yumei Lai, Xuwen Zhao, Gonghong Yan, Dongzhu Ma, Nayra Cardenes, Sruti Shiva, Yongjian Liu, Xiaochun Bai, Yong Jiang, Yu Jiang.   

Abstract

Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth and metabolism. Its activity is controlled by various types of signals, including growth factors, nutrients, and stresses. In this study, we show that changes in expression levels of two antiapoptotic proteins, Bcl-2 and Bcl-XL, also affect mTORC1 signaling activity. In cells overexpressing Bcl-XL, mTORC1 activity is increased and becomes less sensitive to growth factor or nutrient conditions. In contrast, reduction in expression levels of the two antiapoptotic proteins inhibits mTORC1 signaling activity. Our results suggest that the effect of Bcl-2 and Bcl-XL on mTORC1 is mediated by FKBP38, an inhibitor of mTORC1. The two proteins compete with mTORC1 for FKBP38 binding and hence alter mTORC1 activity. This study reveals a novel cross-talk between Bcl-2/XL and mTORC1 signaling, which is likely to contribute to cancer development.

Entities:  

Keywords:  Bcl-2; Bcl-XL; FKBP38; Mitochondria; S6 Kinase; Signaling; mTOR Complex (mTORC); mTORC1

Mesh:

Substances:

Year:  2013        PMID: 23960074      PMCID: PMC3789978          DOI: 10.1074/jbc.M113.505370

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Role of BAX in the apoptotic response to anticancer agents.

Authors:  L Zhang; J Yu; B H Park; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

Review 2.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

3.  The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.

Authors:  Nhan L Tran; Wendy S McDonough; Benjamin A Savitch; Thomas F Sawyer; Jeffrey A Winkles; Michael E Berens
Journal:  J Biol Chem       Date:  2004-12-16       Impact factor: 5.157

4.  A potent cell death activity associated with transient high level expression of BCL-2.

Authors:  E J Uhlmann; T Subramanian; C A Vater; R Lutz; G Chinnadurai
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

5.  Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells.

Authors:  Ming Jiang; Jo Milner
Journal:  Genes Dev       Date:  2003-04-01       Impact factor: 11.361

6.  The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38).

Authors:  Cong Bao Kang; Jeff Tai; Joel Chia; Ho Sup Yoon
Journal:  FEBS Lett       Date:  2005-02-28       Impact factor: 4.124

7.  Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

Authors:  Xiaochun Bai; Dongzhu Ma; Anling Liu; Xiaoyun Shen; Qiming J Wang; Yongjian Liu; Yu Jiang
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

8.  A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.

Authors:  Yun Dai; Mohamed Rahmani; Seth J Corey; Paul Dent; Steven Grant
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

9.  Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis.

Authors:  Michiko Shirane; Keiichi I Nakayama
Journal:  Nat Cell Biol       Date:  2003-01       Impact factor: 28.824

10.  Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.

Authors:  Aline A Fiebig; Weijia Zhu; Catherine Hollerbach; Brian Leber; David W Andrews
Journal:  BMC Cancer       Date:  2006-08-23       Impact factor: 4.430

View more
  9 in total

1.  BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines.

Authors:  Sarah T Diepstraten; Catherine Chang; Lin Tai; Jia-Nan Gong; Ping Lan; Alexander C Dowell; Graham S Taylor; Andreas Strasser; Gemma L Kelly
Journal:  Blood Adv       Date:  2020-01-28

2.  Hypercapnia Inhibits Autophagy and Bacterial Killing in Human Macrophages by Increasing Expression of Bcl-2 and Bcl-xL.

Authors:  S Marina Casalino-Matsuda; Aisha Nair; Greg J Beitel; Khalilah L Gates; Peter H S Sporn
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

3.  FKBP8 recruits LC3A to mediate Parkin-independent mitophagy.

Authors:  Zambarlal Bhujabal; Åsa B Birgisdottir; Eva Sjøttem; Hanne B Brenne; Aud Øvervatn; Sabrina Habisov; Vladimir Kirkin; Trond Lamark; Terje Johansen
Journal:  EMBO Rep       Date:  2017-04-05       Impact factor: 8.807

4.  Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3-Targeted Knockin Mice.

Authors:  Sonia R Singh; Antonia T L Zech; Birgit Geertz; Silke Reischmann-Düsener; Hanna Osinska; Maksymilian Prondzynski; Elisabeth Krämer; Qinghang Meng; Charles Redwood; Jolanda van der Velden; Jeffrey Robbins; Saskia Schlossarek; Lucie Carrier
Journal:  Circ Heart Fail       Date:  2017-10       Impact factor: 8.790

Review 5.  Regulation of PRKN-independent mitophagy.

Authors:  Petra Terešak; Ana Lapao; Nemanja Subic; Patricia Boya; Zvulun Elazar; Anne Simonsen
Journal:  Autophagy       Date:  2021-02-25       Impact factor: 16.016

Review 6.  Regulation of the Target of Rapamycin and Other Phosphatidylinositol 3-Kinase-Related Kinases by Membrane Targeting.

Authors:  Maristella De Cicco; Munirah S Abd Rahim; Sonja A Dames
Journal:  Membranes (Basel)       Date:  2015-09-29

7.  Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.

Authors:  Ulrich-Axel Bommer; Kara L Vine; Prianka Puri; Martin Engel; Lisa Belfiore; Karen Fildes; Marijka Batterham; Alistair Lochhead; Morteza Aghmesheh
Journal:  Cell Commun Signal       Date:  2017-02-01       Impact factor: 5.712

8.  B Cell Receptor Activation Predominantly Regulates AKT-mTORC1/2 Substrates Functionally Related to RNA Processing.

Authors:  Dara K Mohammad; Raja H Ali; Janne J Turunen; Beston F Nore; C I Edvard Smith
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

9.  Smyd1C Mediates CD8 T Cell Death via Regulation of Bcl2-Mediated Restriction of outer Mitochondrial Membrane Integrity.

Authors:  Hui Nie; Gary Rathbun; Haley Tucker
Journal:  J Cell Signal       Date:  2017-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.